Default company panoramic image
48189add b6b8 4be9 beac 670412535ada

The Catalyst Tech Innovation Group

The elimination of back pain through the stabilization / fusion of the sacroiliac (SI) joint.

  • Stage Prototype Ready
  • Industry Biotechnology
  • Location United States
  • Currency USD
  • Founded December 2010
  • Employees 4

Company Summary

The Catalyst Tech Innovation Group (CTIG) is pioneering a new medical device start-up category called “Medical Projects Generator” (MPG), a self funded, crisp, clear three stage value proposition supported by an R&D group out of Switzerland that has a proven track record in both timeline execution and extreme cost containment, independent of medical specialty chosen. The model is differentiated in its ability to 1) uniquely select and finance pro

Team

  • Default avatar
    Richard Ferrari
    Board Chairman

    Rich has been a serial entrepreneur, having been CEO of both private and public companies. He has also founded and managed two successful Venture Capital firms, De Novo Ventures and Saratoga Ventures. De Novo has raised $650MLN in three funds and has invested in 44 companies spanning Medical Devices and Biotechnology.

  • Default avatar
    Dr. Khalid Mentak
    Partner

    Dr. Khalid Mentak is a serial entrepreneur and inventor. He has founded and led several successful medical device companies including, Advanced Vision Science (AVS), Key Medical Technologies (KMTech), and Adoptics AG. In 1997, Dr. Mentak founded AVS to develop the first glistening-free foldable acrylic intraocular lens.

  • Default avatar
    Geoff Dillon
    Partner

    Geoff Dillon has been involved in pioneering numerous medical device technologies and business models during his tenure spanning 30 years, addressing seven different medical specialties along the way. He most recently founded and was CEO of Medical Entrepreneurs II (ME2) in northern California, becoming the first, class III generic medical device company in the world, first foray being that of replicating gold standard replacement heart valves.

  • Default avatar
    Ivan Howard
    Partner

    Ivan brings over 15 years of Wall Street experience in Capital Markets, Alternative Investments, and Wealth Management to the Catalyst Group. Ivan holds an MBA from Mercer University and Masters Degree in Material Science Engineering with emphasis in Biomedical Engineering from the University of Florida. His field of study was Radio Frequency Plasma surface modification of biopolymers used in intraocular lens applications.

  • Default avatar
    Zuehlke Ventures
    Partner

    www.zuehlke.com

Advisors

  • Default avatar
    Wilson Sonsini Goodrich & Rosati
    Lawyer
    Unconfirmed

Previous Investors

  • Default avatar
    Zuhlke Ventures
    Unconfirmed